Even as data submissions were pending from nearly 18 states and five Union Territories, the Central Drugs Standard Control Organisation (CDSCO) reported a total of 205 drug samples as Not of Standard Quality (NSQ) during November 2025.
Talking to Pharma Industrial India, Nikkhil K. Masurkar, CEO, ENTOD Pharmaceuticals, discusses the company’s innovation-led growth strategy and its mission to transform ophthalmic, ENT and dermatology care th...
In an era where pharmaceutical quality and regulatory compliance are under constant scrutiny, the role of water treatment in drug manufacturing has never been more critical. In this interview, Shoeb Kurawadwala, Fou...
India’s MedTech industry stands at a pivotal point of growth and transformation. Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD), explains his vision to Pharma Industrial I...
Shimadzu is incorporating Analytical Intelligence (AI) and advanced software tools to streamline chromatography and mass spectrometry workflows, reduce manual intervention, and support regulatory-compliant method de...
This year, pharma industry finds itself not in a state of flux, but of fusion—where technology, data, and human purpose converge to redefine the very fabric of healthcare innovation. No longer confined to incr...
The Asia-Pacific region, especially countries like India and China, has become a major hub for dermatology CDMOs....
By Darshana Daga
By Pharma Industrial India
Latest news in...
Premas Biotech announced the appointment of Saumen Chakraborty to the Premas Biotech Board of Directors. “I am delighte...
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development o...
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy